• Explore /
  • Poster
  • / First-line chemotherapy versus chemoradiation for resectable distal esophageal adenocarcinoma.

First-line chemotherapy versus chemoradiation for resectable distal esophageal adenocarcinoma.

Abstract Poster

Authors

null

Susanna W. L. de Geus

Boston Medical Center, Boston, MA

Susanna W. L. de Geus , Sameer Hirji , Sing Chau Ng , Teviah E. Sachs , Jennifer F. Tseng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 331)

Abstract #

331

Poster Bd #

C6

Abstract Disclosures

Similar Posters

First Author: dijian shen

Poster

2014 Gastrointestinal Cancers Symposium

Survival impact of esophagectomy after chemoradiation for adenocarcinoma of the esophagus.

Survival impact of esophagectomy after chemoradiation for adenocarcinoma of the esophagus.

First Author: Ravi Shridhar

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Updated pooled analyses of first-line anti-PD1/PD-L1 inhibitors plus chemotherapy in advanced esophageal squamous cell carcinoma.

Updated pooled analyses of first-line anti-PD1/PD-L1 inhibitors plus chemotherapy in advanced esophageal squamous cell carcinoma.

First Author: Maysa Vilbert

First Author: Elena Elimova